Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

C9 anticorps (Center)

L’anticorps Lapin Polyclonal anti-C9 a été validé pour WB et IHC (p) et a été validé indépendamment. Il convient pour détecter C9 dans des échantillons de Humain.
N° du produit ABIN657704

Aperçu rapide pour C9 anticorps (Center) (ABIN657704)

Antigène

Voir toutes C9 Anticorps
C9 (Complement Component C9 (C9))

Reactivité

  • 60
  • 3
  • 2
  • 2
  • 2
  • 2
Humain

Hôte

  • 48
  • 13
  • 2
  • 1
Lapin

Clonalité

  • 50
  • 13
Polyclonal

Conjugué

  • 31
  • 7
  • 4
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp C9 est non-conjugé

Application

  • 48
  • 26
  • 25
  • 20
  • 12
  • 9
  • 8
  • 7
  • 7
  • 6
  • 6
  • 2
  • 2
  • 1
Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Clone

RB33918
  • Épitope

    • 16
    • 8
    • 6
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 191-220, Center

    Specificité

    This C9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 190-220 amino acids from the Central region of human C9.

    Purification

    This antibody is purified through a protein A column, followed by peptide affinity purification.

    Immunogène

    This C9 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 191-220 AA from the Central region of human C9.

    Isotype

    Ig Fraction
  • Indications d'application

    WB = 1:1000, IHC (p) = 1:10-50

    Restrictions

    For Research Use only
  • Validation #102069 (Western Blotting)
    'Independent Validation' signe
    by
    Protein research group, Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense Denmark
    No.
    #102069
    Date
    17.01.2018
    Antigène
    C9
    Numéro du lot
    Application validée
    Western Blotting
    Contrôle positif
    Human endothelial cells with nanoparticle treatment
    Contrôle négative
    Human endothelial cells and astrocytes without nanoparticle treatment
    Conclusion

    Passed. ABIN657704 specifically recognizes C9 in human endothelial cells.

    'Independent Validation' signe
    Validation Images
    Protocole
    Anticorps primaire
    ABIN657704
    Anticorps secondaire
    anti-rabbit IgG HRP-linked antibody (Cell Signaling, 7074S)
    Full Protocol
    • Grow human endothelial cells and astrocytes in EndoGRO-MV Complete Media kit (Millipore, SCME004, lot 2885245) supplemented with serum (Millipore, lot 1000958) at 37°C and 5% CO2 in 8ml on a petri dish to 80-90 % confluency.
    • Add PVP coated silver nanoparticles (50nm Silver Nanospheres, Nanocomposix USA lot no JRC0234) to the endothelial cells for 24h and 48h.
    • Lyse 106 cells in 100µl per well cold lysis buffer (6M Urea, 2M Thiourea, 10mM DTT).
    • Determine total protein content of the lysates using Qubit Protein Assay Kit (ThermoFisher Scientific, Q33211).
    • Denature 20µg of total protein for 5min at 95°C in 5µl Pierce LDS Sample Buffer, Non-Reducing (Thermo Scientific, b31010, lot 151109002) and separate proteins in an XCell SureLock Mini-Cell (Life Technologies, EI0001, lot 007469934) in a Bolt 4-12% Bis-Tris Plus gel (Thermo scientific, NW04125BOX, lot 17120471) for 60min at 100V.
    • Transfer proteins onto PVDF membrane (Sigma-Aldrich, IPFL00005) with a Western blotting system for 20min at 18V.
    • Block the membrane with TBST and 5% non-fat milk powder (Sigma-Aldrich, 70166-500G, lot SZBF3420V) for 1h at RT.
    • Incubation with primary rabbit anti-C9 antibody (antibodies-online, ABIN657704, lot SA110711AL) diluted 1:1000 TBST and 5% non-fat milk powder for ON at 4°C.
    • Wash membrane 3x for 15min with TBST.
    • Incubation with secondary anti-rabbit IgG HRP-linked antibody (Cell Signaling, 7074S) diluted 1:10000 in TBST and 5% non-fat milk powder for 2h at RT.
    • Wash membrane 3x for 15min with TBS.
    • Reveal protein bands using Luminata Forte Western HRP Substrate (Millipore, WBLUF0100) on a UVP multispectral imaging system (AH diagnostics, Denmark).
    • Incubate the membrane in Restore Plus Western blot Stripping Buffer (Thermo Scientific, 46430, lot RL241559) for 20min at RT.
    • Wash membrane 3x for 15min with TBST.
    • Incubation with rabbit anti-GAPDH antibody (Cell Signaling Technology, 2118) diluted 1:5000 in TBST and 5% non-fat milk powder for 2h at RT.
    • Wash membrane 3x for 15min with TBS.
    • Reveal protein bands as described above.
    Notes

    Upon addition of the nanoparticles, the endothelial cells’ proteome revealed high expression of C9 at the 24h time point and reduced expression at the 48h time point. We validated the proteomics results by western blotting and we confirm that the C9 antibody ABIN657704 reveals a protein of the expected molecular weight (60kDa) in lysates of endothelial cells. The protein band is only visible in the nanoparticle treated cells but not the negative controls.

  • Format

    Liquid

    Concentration

    0.36 mg/mL

    Buffer

    PBS with 0.09 % (W/V) sodium azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Stock

    4 °C/-20 °C

    Stockage commentaire

    C9 Antibody (Center) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.

    Date de péremption

    6 months
  • Antigène

    C9 (Complement Component C9 (C9))

    Autre désignation

    C9

    Sujet

    This gene encodes the final component of the complement system. It participates in the formation of the Membrane Attack Complex (MAC). The MAC assembles on bacterial membranes to form a pore, permitting disruption of bacterial membrane organization. Mutations in this gene cause component C9 deficiency. [provided by RefSeq].
    Synonyms: Complement component C9,C9,

    Poids moléculaire

    63173 DA

    ID gène

    735

    NCBI Accession

    NP_001728

    UniProt

    P02748

    Pathways

    Système du Complément
Vous êtes ici:
Chat with us!